
    
      This study, previously posted by GlaxoSmithKline (GSK), was transitioned to Convergence
      Pharmaceuticals, Ltd., which spun off from GSK. Convergence Pharmaceuticals, Ltd., has now
      been acquired by Biogen.
    
  